These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

407 related items for PubMed ID: 8282017

  • 1. Further assessment of the antagonist properties of the novel and selective 5-HT1A receptor ligands (+)-WAY 100 135 and SDZ 216-525.
    Lanfumey L, Haj-Dahmane S, Hamon M.
    Eur J Pharmacol; 1993 Nov 02; 249(1):25-35. PubMed ID: 8282017
    [Abstract] [Full Text] [Related]

  • 2. Interactions of lesopitron (E-4424) with central 5-HT1A receptors: in vitro and in vivo studies in the rat.
    Haj-Dahmane S, Jolas T, Laporte AM, Gozlan H, Farré AJ, Hamon M, Lanfumey L.
    Eur J Pharmacol; 1994 Apr 01; 255(1-3):185-96. PubMed ID: 8026543
    [Abstract] [Full Text] [Related]

  • 3. Effect of the putative 5-HT1A antagonists WAY100135 and SDZ 216-525 on 5-HT neuronal firing in the guinea-pig dorsal raphe nucleus.
    Mundey MK, Fletcher A, Marsden CA.
    Neuropharmacology; 1994 Jan 01; 33(1):61-6. PubMed ID: 8183439
    [Abstract] [Full Text] [Related]

  • 4. Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist.
    De Vry J, Schohe-Loop R, Heine HG, Greuel JM, Mauler F, Schmidt B, Sommermeyer H, Glaser T.
    J Pharmacol Exp Ther; 1998 Mar 01; 284(3):1082-94. PubMed ID: 9495870
    [Abstract] [Full Text] [Related]

  • 5. SDZ 216-525, a selective and potent 5-HT1A receptor antagonist.
    Schoeffter P, Fozard JR, Stoll A, Siegl H, Seiler MP, Hoyer D.
    Eur J Pharmacol; 1993 Feb 15; 244(3):251-7. PubMed ID: 8384569
    [Abstract] [Full Text] [Related]

  • 6. New methoxy-chroman derivatives, 4[N-(5-methoxy-chroman-3-yl)N- propylamino]butyl-8-azaspiro-(4,5)-decane-7,9-dione [(+/-)-S 20244] and its enantiomers, (+)-S 20499 and (-)-S 20500, with potent agonist properties at central 5-hydroxytryptamine1A receptors.
    Kidd EJ, Haj-Dahmane S, Jolas T, Lanfumey L, Fattaccini CM, Guardiola-Lemaitre B, Gozlan H, Hamon M.
    J Pharmacol Exp Ther; 1993 Feb 15; 264(2):863-72. PubMed ID: 8094756
    [Abstract] [Full Text] [Related]

  • 7. Biochemical, electrophysiological and neurohormonal studies with B-20991, a selective 5-HT1A receptor agonist.
    Caicoya AG, Beneytez ME, Delgado M, Manzanares J, López-Rodríguez ML, Benhamu B, Morcillo MJ, Pozo MA, Rubia FJ, Fuentes JA.
    Pharmacology; 2001 May 15; 62(4):234-42. PubMed ID: 11360001
    [Abstract] [Full Text] [Related]

  • 8. The putative 5-HT1A receptor antagonist DU125530 blocks the discriminative stimulus of the 5-HT1A receptor agonist flesinoxan in pigeons.
    Mos J, Van Hest A, Van Drimmelen M, Herremans AH, Olivier B.
    Eur J Pharmacol; 1997 May 01; 325(2-3):145-53. PubMed ID: 9163561
    [Abstract] [Full Text] [Related]

  • 9. The novel 5-HT1A receptor antagonist, SDZ 216-525, decreases 5-HT release in rat hippocampus in vivo.
    Sharp T, McQuade R, Fozard JR, Hoyer D.
    Br J Pharmacol; 1993 Jul 01; 109(3):699-702. PubMed ID: 8102935
    [Abstract] [Full Text] [Related]

  • 10. (-)Tertatolol is a potent antagonist at pre- and postsynaptic serotonin 5-HT1A receptors in the rat brain.
    Jolas T, Haj-Dahmane S, Lanfumey L, Fattaccini CM, Kidd EJ, Adrien J, Gozlan H, Guardiola-Lemaitre B, Hamon M.
    Naunyn Schmiedebergs Arch Pharmacol; 1993 May 01; 347(5):453-63. PubMed ID: 7686633
    [Abstract] [Full Text] [Related]

  • 11. S 14671: a naphtylpiperazine 5-hydroxytryptamine1A agonist of exceptional potency and high efficacy possessing antagonist activity at 5-hydroxytryptamine1C/2 receptors.
    Millan MJ, Rivet JM, Canton H, Lejeune F, Bervoets K, Brocco M, Gobert A, Lefebvre de Ladonchamps B, Le Marouille-Girardon S, Verriele L.
    J Pharmacol Exp Ther; 1992 Aug 01; 262(2):451-63. PubMed ID: 1323650
    [Abstract] [Full Text] [Related]

  • 12. Effects of WAY 100635 and (-)-5-Me-8-OH-DPAT, a novel 5-HT1A receptor antagonist, on 8-OH-DPAT responses.
    Trillat AC, Malagié I, Mathé-Allainmat M, Anmela MC, Jacquot C, Langlois M, Gardier AM.
    Eur J Pharmacol; 1998 Apr 17; 347(1):41-9. PubMed ID: 9650846
    [Abstract] [Full Text] [Related]

  • 13. In vivo characterization of the putative 5-HT1A receptor antagonist SDZ 216,525 using two models of somatodendritic 5-HT1A receptor function.
    Routledge C, Hartley J, Gurling J, Ashworth-Preece M, Brown G, Dourish CT.
    Neuropharmacology; 1994 Apr 17; 33(3-4):359-66. PubMed ID: 7984274
    [Abstract] [Full Text] [Related]

  • 14. 5-HT1D as well as 5-HT1A autoreceptors modulate 5-HT release in the guinea-pig dorsal raphé nucleus.
    Starkey SJ, Skingle M.
    Neuropharmacology; 1994 Apr 17; 33(3-4):393-402. PubMed ID: 7984277
    [Abstract] [Full Text] [Related]

  • 15. Central pre- and postsynaptic 5-HT1A receptors in rats treated chronically with a novel antidepressant, cericlamine.
    Jolas T, Haj-Dahmane S, Kidd EJ, Langlois X, Lanfumey L, Fattaccini CM, Vantalon V, Laporte AM, Adrien J, Gozlan H.
    J Pharmacol Exp Ther; 1994 Mar 17; 268(3):1432-43. PubMed ID: 8138956
    [Abstract] [Full Text] [Related]

  • 16. Behavioural response to pharmacologic manipulation of serotonin receptors in the genetically dystonic hamster.
    Richter A, Löscher W.
    Pharmacol Biochem Behav; 1995 Dec 17; 52(4):655-65. PubMed ID: 8587901
    [Abstract] [Full Text] [Related]

  • 17. Identification and role of serotonin 5-HT1A and 5-HT1B receptors in primary cultures of rat embryonic rostral raphe nucleus neurons.
    Héry F, Boulenguez P, Sémont A, Héry M, Becquet D, Faudon M, Deprez P, Fache MP.
    J Neurochem; 1999 May 17; 72(5):1791-801. PubMed ID: 10217255
    [Abstract] [Full Text] [Related]

  • 18. Early desensitization of somato-dendritic 5-HT1A autoreceptors in rats treated with fluoxetine or paroxetine.
    Le Poul E, Laaris N, Doucet E, Laporte AM, Hamon M, Lanfumey L.
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Aug 17; 352(2):141-8. PubMed ID: 7477436
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Induction of hypothermia as a model of 5-hydroxytryptamine1A receptor-mediated activity in the rat: a pharmacological characterization of the actions of novel agonists and antagonists.
    Millan MJ, Rivet JM, Canton H, Le Marouille-Girardon S, Gobert A.
    J Pharmacol Exp Ther; 1993 Mar 17; 264(3):1364-76. PubMed ID: 8450471
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.